Paige.ai has now raised $75m to date, with the latest funding set to help refine its cancer pathology software offering.

Utimco-backed accountable care services network Aledade attracted GV and Echo Health Ventures for its latest round.

Cash Capital provided up to $42.4m for the iris recognition technology developer, following a Gree Electric investment in September.

GV and Takeda have backed a series B round that will fund the Rockefeller University spinout's identification of targets for brain disease treatments.

CTC Capital has led an $58m series E round for AISpeech, a natural language processing technology developer already backed by TusPark Ventures.

Based on research at Grousbeck Gene Therapy Center and Massachusetts Eye and Ear, Affinia has raised $60m in a series A round to advance its gene therapies into the clinic.

Bpifrance supplied funding through three separate units to help take Satt Conectus-allied rare disease drug developer Dynacure's latest round to $55m.

UT Southwestern spinout Recode Therapeutics has completed an oversubscribed $80m series A round featuring Osage University Partners.

The Montana State University-backed edible protein developer has rebranded from Sustainable Bioproducts and received series B funding.

University of Wisconsin-Madison gene medicine developer Design Therapeutics has attracted SR One for its series A round.